XTX Topco’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-261,293
Closed -$1.87M 4212
2025
Q4
$1.87M Buy
261,293
+146,001
+127% +$1.15M 0.05% 605
2025
Q3
$1.23M Buy
115,292
+104,198
+939% +$1.02M 0.06% 445
2025
Q2
$107K Buy
+11,094
New +$114K ﹤0.01% 1872
2025
Q1
Sell
-16,840
Closed -$251K 2893
2024
Q4
$251K Sell
16,840
-21,383
-56% -$348K 0.02% 1362
2024
Q3
$731K Buy
38,223
+5,219
+16% +$108K 0.05% 574
2024
Q2
$683K Buy
+33,004
New +$656K 0.06% 514
2021
Q4
Sell
-7,661
Closed -$251K 909
2021
Q3
$251K Buy
+7,661
New +$245K 0.08% 406

Other funds holding OGN

XTX Topco's OGN Position: Q1 2026 in Review

XTX Topco sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 261,293 shares — an estimated $1.87M sold.

XTX Topco first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $1.87M in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • XTX Topco reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 261,293 Organon & Co shares in Q1 2026, an estimated $1.87M.
  • XTX Topco first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • XTX Topco's Organon & Co position peaked at $1.87M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.